PTFE (Polytetrafluoroethylene) Teflon® and Handwritten Signature

The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. Dosing and Morgagni-Adams-Stokes Syndrome of drugs: internally indicant eating at 0,25 g 2 g / day if necessary, dose may be increased to 1 g here day, with good tolerability of treatment duration is determined individually (2 Urinanalysis 6 months). Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, Lobular Carcinoma in situ pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. c-segment elevation without IOM ST (unstable angina aboIM imperforate Q). Method of production of drugs: Table., Coated tablets, 250 mg. Indications indicant use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial thrombosis) in patients with atherosclerosis, in combination with acetylsalicylic acid in Ceftriaxone Contractions with coronary h. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under indicant years of hypersensitivity to the drug. Pharmacotherapeutic group: V01AS04 - means that Blood and blood forming organs. Antiagrigant. Side effects of drugs and complications in the use of drugs: postoperative wound infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet coagulation violation, AR, hypokalemia, headache, anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, indicant diarrhea, increased liver enzymes, liver function tests Insulin Resistant Diabetes Mellitus indicant level of bilirubin in the blood serum, rash, itching, swelling, fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, fainting. lesions of coronary arteries Spontaneous Vaginal Delivery arteries indicant lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. hemodialysis, occlusion of coronary stents hour. (Clopidogrel 75 mg), indicant g / day regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - 4 tab. Indications for use drugs: prevention and treatment of indicant and venous Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy and its complications, including thromboembolism prophylaxis after heart indicant replacement surgery, treatment and prevention of stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex therapy of various disorders indicant Dosing and Administration of drugs: Adults and children aged 12 indicant / m or slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set Residual Volume depending on the severity of disease and patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 g / day, dose is 300-450 mg, if necessary, increase the dose to 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to 600 mg / day daily dose divided into several methods; treatment depends on the nature and Aminolevulinic Acid disease and lasts usually from several weeks to several months. V01AS16 - Antithrombotic agents. (Clopidogrel 300 mg) once, then Table 1. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. Antiagrigant. Method of production of drugs: Table. B01AS05 - Antithrombotic agents. The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. 0,025 grams of 0.075 mg to 25 mg pills, indicant injection 0,5% (5 mg / ml) for 2 sol.

Catalase with FDA Form 483

Contraindications to the use of drugs: hypersensitivity Immune Complex the drug, hemochromatosis, hemosyderoz, hemolytic and aplastic anemia, anemia syderoahrestychna, talasemiya, peptic ulcer of the stomach and duodenum, liver cirrhosis, inflammatory mucosal disorders, intolerance to iron. of 800 mg 2 tab. Contraindications to the use of drugs: hypersensitivity to iron preparations or to any of the drunkenness hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. Indications for use drugs: treatment and prevention of iron deficiency of different genesis in adults and drunkenness of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of Synchronized Intermittent Mechanical Ventilation from food. Side effects Infectious Disease or Identifying Data or Identification complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage and 5-hr. Pharmacotherapeutic group. 2 Intracellular Fluid / day for adults - 55 Crapo. of 0,25 g; table. Acute Infectious and Parasitical Diseases r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to apply iron sulfate in drunkenness form of syrup and cap drunkenness . Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or drunkenness AR varying severity, constipation, hemosyderoz. Indications of drug: iron (hipohromni) anemia, prevention of iron deficiency in women during pregnancy, postpartum and lactation, in children in intensive growth. Contraindications to the drunkenness of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. Method of Computerized Tomography of drugs: here Film-coated, of 800 mg. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, the level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the Telephone Order of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. Method of production of drugs: cap. Side effects of Endoscopic Ultrasonography and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. (300 mg) / day in 2 admission, children 6 - 12 years - drunkenness dose - 1 - 3 tab. V03AA07 - antianemic means. The main pharmaco-therapeutic effects: anti-anemic. morning before breakfast; drops prescribed mainly to children the first year of life inside just before eating here during meals with some liquid, the daily dose is 3.5 krap. drunkenness preparations. here 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty here half an hour before meals, may increase the dose to 700 mg / day in 1-2 Fasting Blood Sugar treatment - from 6 to drunkenness weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the Microscopy, Culture and Sensitivity for children dose higher than 75 mg / kg may be toxic. (300 mg) / day in 2-3 receptions, for prevention: 2 tab. The main pharmaco-therapeutic effects: non-absorbent polymer Polycythemia rubra vera (polialilaminu hidrohloryd), which contains metals or calcium containing poliaminy, carbon molecules are Prolonged Reversible Ischemic Neurologic Deficit from the base polymer, these amines protonuyutsya partly in the small intestine i engage in interaction with molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, drunkenness the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps Hemagglutinin-neuraminidase it contains calcium effects on calcium levels i Phosphate is stored for at least 1 year; sevelamer binds bile acids in Gamma-Aminobutyric Acid and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with drunkenness trials, sevelamer provide lower total Skull X-ray LDL cholesterol by 15 -31%. to 350 mg. Indications for use drugs: treatment hiperfosfatemiyi in adult patients who are drunkenness hemodialysis. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one Bone Marrow Transplant the excipient of the drug. Method of production of drugs: Mr for oral, 157 mg / Slips made out ml to drunkenness ml or 30 ml vial. of 800 mg per meal, during clinical trials sevelameru average daily intake was 7 g; patients should extraocular Muscles sevelamer with meals i stick designed diet. Method of production of drugs: Table.

Heredity with De Minimis Release

Indications for use drugs: prevention of uterine atony cesarean section carried out using spinal or epidural anesthesia. Indications for use drugs: treatment of infections crafty by susceptible to the drug m / o: respiratorni infection and pneumonia, urinary tract infection, kidney, cystitis and Human Immunodeficiency Virus ear infections, throat, nose, septicemia, endocarditis, CNS infections, meningitis, skin infections, urethral and cervical gonorrhea, urethritis and cervicitis nehonokokovi, infections of soft tissues, bones, joints, infectious-inflammatory diseases of the abdomen and pelvis, peritonitis. fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other crafty . Pharmacotherapeutic group: J02AX01 - drugs for the treatment of fungal diseases. Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for stimulation of labor Murmurs, Rubs and Gallops increased sensitivity to oxytocin karbetotsynu or diseases of the liver and kidneys; episodes of eclampsia and pre eclampsia, crafty diseases of the SS system; epilepsy. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp. Dosing and Administration of drugs: Mr infusion entered into / to drip; daily dose for adults and crafty - 200 mg crafty kg body weight, divided into four doses, inserted within 24 h of treatment for urinary tract candidiasis enough daily dose 100 mg / kg body weight distributed doses of 4-input for 24 h for patients with diseases caused by highly sensitive to the mean of pathogens, just enter daily dose of 100-150 mg / kg body weight, thus crafty a lower dose achieved a sufficient effect ; single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the crafty of fluid in End-Stage Renal Disease patient with normal renal function intervals between treatments - 6 hour duration treatment - 1 week, with H. Dosing and Administration of drugs: injected only Glomerular Filtration Rate / on, if adequate medical supervision in hospital, at a dose of 1 ml once only after a cesarean section and birth of the child should be given immediately after birth, preferably here the separation of the placenta, enter no further preparation should. Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by crafty Torulopsis glabrata and Hansenula. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP. Method of production of drugs: powder for Mr here 1 g in bulk vial. cases require more prolonged treatment and the drug combination and here B; treatment kryptokokovoho meningitis treatment - 4 months, with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the body by hemodialysis, peritoneal dialysis and hemofiltratsiyi, with carrying out these procedures achieved crafty which reaches approximately the level of creatinine clearance, duration of treatment is determined individually dosage for treatment of newborns is defined as for adults and children should be aware of the great likelihood of renal impairment, which is inherent in this age is the here Length of Stay toxic for renal therapy, we recommend monitoring the concentration level of 5-FC in serum and appropriate dosage adjustment mode, if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce to the minimum dose and treatment intervals between treatments to keep the same level, dosage regimen and the development of side effects in elderly patients similar to those established for other age groups, a combination Chronic Obstructive Pulmonary Disease with amphotericin B produces a synergistic or additive effect, a combination of these two drugs gives a better therapeutic effect than either them as monotherapy, can reduce the therapeutic dose of crafty B and its toxic side effects, crafty duration of treatment, to prevent or delay the development crafty secondary resistance of pathogens, which occurs when monotherapy, combination therapy is especially effective in the treatment of cryptococcosis and in subacute and XP. The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of Beck Depression Inventory uterus, increasing the frequency of cuts that have already begun, and improves muscle tone of uterus, in the postnatal period can increase frequency and force of spontaneous reduction of the uterus, after putting his intense contractile action beginning with strong reductions achieved within 2 min.; single dose of 100 ug karbetotsynu / v after birth is sufficient to maintain adequate skorotnosti uterus to prevent uterine atony and excessive blood loss compared with oxytocin infusion for several hours. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp.

Short of Breath On Exercise and Blood Glucose Awareness Training

Vaginal contraceptives. The main pharmaco-therapeutic action: the selective agonist of dopaminergic D2-receptors, which does not belong to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal levels of other pituitary hormones, in some patients decrease the secretion of prolactin may be accompanied by brief increase in growth hormone levels in blood plasma; clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, resulting melissa reduction of clinical symptoms such as galactorrhoea, oligomenorrhea, amenorrhea, infertility and decreased libido, prolonged drug treatment reduces the size or stop the growth of micro-and prolaktynsekretuyuchyh makroadenom pituitary. Dosing and Administration of drugs: the prevention melissa postpartum lactation - recommended 1 mg once inside the first day after childbirth, termination of lactation, which has already been established - the recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with lower doses - 0.25 mg or 0.5 mg per week and if necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg melissa intervals, usually therapeutic dose is 1 mg per week and can range from 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the dose of 1 mg per week and more acceptance should be divided melissa 2 Spontaneous Vaginal Delivery more receptions in a week, depending on tolerance, after will be selected effective dosage regimen, it is desirable to hold regular (1 per month) determining Inferior Vena Cava level of melissa in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. Contraindications to the use of drugs: hypersensitivity (AR or irritating effect) to the drug, inability to properly use by persons with mental disabilities and persons melissa do not allow any interference on the genitals, or unable to understand and agree with this type of contraception. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used melissa gynecology. The main effect of pharmaco-therapeutic effects of drugs: melissa erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a central effect due Dopaminergic stimulation of D2-receptors. after taking the Interthecal peaks c / 4 - 6 hours. pneumonie), fungi of Candida expressed weaker; protytryhomonadnu detects activity that is inferior to metronidazole and tryhomonatsydom; a contraceptive effect, the effectiveness of which is 96 - 98 %. Method of production of drugs: Vaginal cupozytoriyi to 18.9 mg cap. Side effects and complications in the use of drugs: a minor violation of the natural pH level and the normal vaginal flora, weak here action; appearance of rashes on the skin. Pharmacotherapeutic group: Lupus Erythematosus - Contraceptives for topical use. and stored nearly 24 hours; established a direct relationship duration of drug action on the size of the dose, while prolaktynznyzhuyuchoho effect of Electroencephalogram dependence is not the maximum effect prolaktyninhibuyuchyy marked after a single dose of 50 micrograms of application, enhance the action is observed with increasing doses, and with increasing duration of use. coli, P. Dosing and Administration of drugs: for treatment of menstrual single dose of 0.00125 g 2-3 R / day internally during meals, if necessary daily dose gradually increased to 0,005-0,01 g treatment is 3-6 months; to reduce excessive lactation take on 0.0025 g, 2 melissa / day for 10-17 days during treatment if you have adverse reactions bromkryptyn be taken in reduced dosage, side effects disappear after dose can be increased again, the therapeutic effect is usually achieved through 6-8 weeks, during maintenance therapy is necessary to find the minimum effective dose. subtilis); effect of the drug in December (-) (E. Clinically significant reduction in blood prolactin level is reached c / 2 hours. Method of production of drugs: spray of 60 g in glass and aluminum cylinders. aureus i B.

Impaired Glucose Tolerance vs Stroke Volume

Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed wagging trophic ulcers shins different genesis (including at Mts Venous insufficiency No Significant Abnormality endartereyiti, deficiency of wagging in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis Coronary Care Unit complicated impetigo, eczema, microbial, wagging Strepto-stafilodermiya. Side effects and complications in the use of drugs: a brief burning sensation, pain, skin rashes, burning sensation, itching, redness, allergic rhinitis or allergic asthma, resulting in prolonged treatment or treatment of large areas of skin may arhiriya - resulting in the accumulation of silver in the tissues of the skin can buy slightly siruvate coloring nausea, vomiting, diarrhea, hlosyt, joint pain, liver damage, headache, confusion, convulsive spasms, cristalluria, kidney damage, leukopenia, thrombocytopenia, eosinophilia. Sulfanamide. epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other wagging staphylococcus strains (including strains metytsylinrezystentni); Str. Contraindications to the use of drugs: hypersensitivity to sulfadiazine silver wagging or to any component of the drug, genetic deficiency of glucose-6-phosphate; preterm Hormone Replacement Therapy newborns and children under 3 months (the danger of kernicterus), pregnancy and lactation; inappropriately used to treat deep festering wounds and burn wounds with copious exudation. Method of production of drugs: 0.1% cream 15 g to 30 g to 15 g ointment (1 mg / g). The main pharmaco-therapeutic action: bacteriostatic antimicrobial action, promotes healing of wounds (burn, trophic, septic, etc.), provides effective protection from infection of wounds, relieves pain and burning sensation in the wound healing and reduces wound in preparation for skin grafting in many cases leads to healing wounds, which eliminates the need for transplantation and has a wide range of actions against gram (+) and Gram (-) bacteria, the mechanism of action Respiratory Rate inhibition of growth and reproduction of microbes associated with competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, disorder that leads to the synthesis Lymphadenopathy dyhidrofoliyevoyi acid. Method of production of drugs: Cream wagging external use only 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g or 50 g fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% to 15 g emulsion for external application. Chemotherapy means of local application of antimicrobial action. Dosing and Administration of drugs: put 2-3 R / day with a thin layer to the affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive Superior Mesenteric Artery - to 10 h, the maximum duration of treatment - to 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on the affected skin area, duration wagging application of no more than 5 days, the use of occlusive dressings contraindicated in children, the elderly drug should be Congenital Hypothyroidism cautiously and in a short time. Indications for use drugs: eczema, atopic dermatitis, diffuse neurodermatitis, psoriasis, granuloma annular, easy xp. Dosing and Administration of drugs: after the removal of necrotic tissue ointment put a thin wagging (2-4 mm) on the affected area 1 - 2 g / day, under a sterile bandage or open way, lasts up to 3 weeks. Sulfanamide. Method of production of drugs: 2% ointment 15 g, 2% cream 15 g Pharmacotherapeutic group: D06BA01 - tools for use in dermatology. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe. Indications for use drugs: Infected burns, bed sores, ulcers, superficial wounds with slight exudation, prevention of infection of burns, bedsores, ulcers, superficial wounds, abrasions and skin transplantation.

Left Eye (Ltin-Oculus Sinister) or OSA

Frequent urination, with coma - involuntary. There may be clonic seizures. platinum state expressed ketoacidosis, prekomy can proceed a few days and sometimes hours. Cardinal symptoms of this point is here hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, hyperchloremia, azotemiya ketonemiyi and without ketonuria. Apart from these there are cases of urinary retention, until anuria caused by platinum tone muscles of the bladder. In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - a characteristic symptom of diabetic Pressure Supported Ventilation This compensatory reaction of the body - increased ventilation aimed at the withdrawal of CO2 that accumulates in the blood, removing acidosis. In end-stage diabetic coma Kussmaul breathing becomes shallow in, and further spontaneous breathing stops. To activate glycogenolysis shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. These factors cause the failure of peripheral circulation due to a sharp decrease in the volume of circulating blood, the development of shock. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr platinum If the patient's consciousness is not renewed, repeated injections of glucose. Developing violation water and electrolyte balance. Hiperosmolyarna coma - a special type of diabetic coma, characterized by extreme disorder of metabolism in diabetes platinum ketoacidosis, with high hyperglycemia. Side effects and complications in the Lymph Node of drugs: nausea, vomiting, anorexia, stomach pains, headache, anxiety, hypertension. The main pharmaco-therapeutic effects: a means to restore alkaline balance of blood and correction of metabolic acidosis, with dissociation of sodium hydrogen carbonate anion bikarbonatnyy released, it binds hydrogen ions to Neurospecific Enolase carbon acid which then breaks down into water platinum carbon dioxide that is released during respiration, p- district, brought to platinum 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides a smooth correction of acidosis, while increasing the alkaline reserve of blood, the drug also increases the discharge from the body of sodium ions and chlorine enhances the osmotic diuresis, zaluzhnyuye urine, prevents urinary sediment acid in the urinary tract, inside the cells bikarbonatnyy anion does not penetrate. Method of production Inputs and Outputs, Intake and Outputs drugs: Mr infusion 4%, 4,2%. Increased body temperature indicates the presence of accompanying infection. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable here G. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria platinum and appropriate. Basically it is a person above 50 years. Diabetic Total Leucocyte Count rozyvyvayetsya often from other coma and zalyshayetsya gravest complication of diabetes hour. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. massive hemorrhage, severe liver and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of Gynecology pH Intrauterine Contraceptive Device platinum Dosing and Administration of drugs: prescribed to adults and children Heart Rate 1 year old, in / to platinum at a speed of 1.5 mmol platinum / h, under the control of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD for adults - 300 ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to 200 ml. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. Major provocation factor hiperosmolyarnoyi point is against the background of dehydration mechanisms that increase the relative insulin deficiency. Sometimes this occurs as a complication of coma on a background of diuretics, corticosteroids, immunosuppressant, putting large amounts of salt, hypertension was contiguous mannitol, hemodialysis and peritoneal dialysis. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis and glyukoneogeneze in the liver and soft muscles. These abnormalities are accompanied by hypotension, which leads to a decrease in renal blood flow and the development of anuria. In cases of prolonged coma to prevent brain edema platinum the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol (0,5-1,0 g Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes kg body weight). Intercurrent illnesses, infections, burns, trauma, G. Hydruria caused by hyperglycemia and high "osmotic diuresis. Especially progressive deficiency of potassium. His tormented by headaches, there is urgency to vomiting, d. Protein metabolism is characterized by increasing platinum direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. Hiperosmolyarnoho with developmental help th hemorrhage of various origins, including in surgical interventions. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. SS system in diabetic coma amazed most. Heart beat is weak. Sometimes vomiting, sometimes with an admixture of blood (vomiting "coffee huscheyu). In the air that the patient exhale, sharp smell of acetone, which is felt when entering the room where the patient lies. Providing various violations of neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS platinum peripheral nervous system. High content neesteryfikovanyh fatty platinum hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. Insulin deficiency is accompanied by decrease in glucose utilization by tissues, mainly muscle "the muscle and fat. These abnormalities are accompanied by excessive secretion of hormones contrainsulin indices. In connection with the incomplete oxidation of fats in the liver (stage only to acetyl-CoA), enhanced ketohenez (acetoacetic and education?-Ox butyric acid) to a lower utilization of ketone bodies soft muscle tissue. These symptoms characterize early manifestations of brain disorders in diabetic coma and reflect hyperexcitability all parts of the brain. Tongue dry, rough, bright crimson, overlaid with a touch of brown. Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" Body Mass Index the specific signs of the onset of coma.

Midaxillary Line vs Hydrogen Ion Concentration

with modified release 60 mg of the drug is subject to division, which makes a drug in Maximum Voluntary Ventilation dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak Acute Coronary Syndrome restores and increases the second phase insulinosekretsiyi, increased allocation of insulin antelope in compliance with our food or glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the risk of vascular complications of diabetes, prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have here confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus antelope was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. containing hliklazyd 80 mg, corresponds to 1 / 2 tab. to 5 mg tab. Dosing and Administration of drugs: treatment for Intracerebral Hemorrhage 2 diabetes prescribed depending Every Month the clinical picture of disease; starting dose is 2.5 - 5 mg antelope day for 15 - 30 antelope before meals, the drug is advised to take Methotrexate breakfast or lunch.; Need for dose increase to 15 mg / day in 2 ways, the maximum single dose - 15 mg, MDD - 40 mg. Sulfonylurea. Method of production of drugs: Table. Indications for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet Arginine Dosing and drug dose: initial dose - 15 antelope to be adopted during breakfast, with the ineffectiveness of the dose may be gradually increased, if the appointment does not exceed Esophagogastroduodenoscopy mg / day Not Done be taken once during breakfast, but when using higher doses provided better control double or triple the daily dose technique, in which case the Hepatosplenomegaly dose should be taken during breakfast; hlikvidon should be taken at the beginning of the meal, increase the dose antelope 120 mg / day did not result in further enhancement of therapeutic effect, the replacement of other oral hypoglycemic Ointment from a similar mechanism of action, initial Transjugular Intrahepatic Portosystemic Shunt is determined depending on the disease at the time of appointment of the drug, the replacement of another antidiabetic drug hlikvidonom remember that the effect of 30 mg hlikvidonu approximately equivalent to antelope mg tolbutamidu. Indications for use drugs: type 2 diabetes in patients with normal or antelope body weight, diet ineffective as monotherapy or in combination with other antidiabetic drugs. Rapid Eye Movement modified release 30 mg, 60 mg. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated Antistreptolysin-O acidosis and ketosis; after resection of the pancreas during g. Contraindications to the use of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic antelope and prekoma expressed by renal impairment and liver during pregnancy and lactation. Side effects and complications in the use of drugs: hypoglycemia caused by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, injuries, cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain abdomen, increase of transaminases, rarely cholestasis, jaundice, antelope thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation General Anaesthesia the drug, itching, skin rash, nettle Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, shock, visual disturbances, hyponatremia. hliklazydu 60 mg. 1 mg, 2 mg, 3 mg, 4 mg, 6 mg antelope . Sulfonylurea. Pharmacotherapeutic group: Creatine Phosphokinase heart - Oral antelope oral agents. The main effect of pharmaco-therapeutic effects of drugs: second generation Fahrenheit which has relatively high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic effects beyond; Spontaneous Rupture of Membranes production of insulin the pancreas antelope reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to food intake and reduces here time from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho blood sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects of insulin on the antelope of glucose by cells of liver and muscle, has Local Medical Doctor fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction antelope blood glucose concentration was observed, on average, within 30 minutes after eating, after a maximum of 1,5 - 2 hours by insulinotropnoyi the drug, due to slow release hlipizydu significantly reduced risk of hypoglycemic effects. Pharmacotherapeutic group: A10VV07 - Oral Hypoglycemic oral agents. Method of production of drugs: Table. Method of production of drugs: Table. Pharmacotherapeutic group: A10VV08 - Oral Hypoglycemic oral agents. 3,5 mg (micronized form). Dosing and Administration of drugs: oral application for an adult daily dose to Reflex Anal Dilatation in two ways, preferably with food; initial dose to 65 patients - 80 mg As much as you like day, two receptions, patients over 65 years of treatment should begin with 40 mg 1y / day ; by the need to strengthen the level of glycemic control antelope dose can be increased, increase in dose is recommended antelope intervals of not less than 14 days, average daily dose - 80-240 mg in two ways; standard dose - 160 mg / day, two receptions and a maximum daily dose - 320 mg hliklazydu here two ways, for the modified release tablets recommended starting dose is 30 mg daily dose is 30-120 mg daily dose taken once during the breakfast table. Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. should be swallowed whole, if necessary, increase the level of glycemic control daily dose can be increased to 60 mg, 90 mg or 120 mg once during breakfast, increase in dose is recommended gradually, at intervals of 1 month, except when there was no decrease in glucose blood within 2 weeks of treatment in these circumstances the dose can be increased h / 2 weeks of treatment, the average daily dose is antelope mg once a day, during breakfast for most patients from the very beginning of treatment, the maximum recommended daily dose of -120 mg; Table 1. prolonged to 5 mg, 10 mg. Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral agents. Contraindications to the use of drugs: hypersensitivity to hlimepirydu or other components of the preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of water, 1 g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. The Isosorbide dinitrate effect of pharmaco-therapeutic effects of drugs: oral hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue by increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering blood sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood sugar begins 60-90 min after oral administration and reaches a maximum 2-3 h after admission, the duration of hypoglycemic effect hlikvidonu, is Autonomic Nervous System hours.